Retour aux projets

11667.1;4 PFLS-LS

Development of a 18F-PET Folate Tracer for Diagnosis and Therapy Planning of Cancer Diseases

Résumé

Development of a 18F-PET Folate Tracer for Diagnosis and Therapy Planning of Cancer Diseases

Textes supplémentaires

Abstract

Non-invasive, nuclear imaging techniques such as positron emission tomography (PET) are crucial for cancer diagnosis, treatment planning and monitoring. The folate receptor (FR) is a promising cancer-related target because it is overexpressed in a wide variety of tumor types. We will develop the first clinically useful PET-folate tracer, which is expected to be of major clinical and health economical relevance as it serves not only for diagnostic purposes but also for identification of patients, who profit from FR-targeting therapies.

Participants

Roger Schibli

Kontaktperson

roger.schibli@pharma.ethz.ch

ETH Zürich Roger Schibli Wolfgang-Pauli-Strasse 10 Institute of Pharmaceutical Science 8093 Zürich ZH CH

Détails du projet

Office de recherche
INNOSUISSE
Statut du projet
Abgeschlossen
Type de projet
Forschungsprojekt
Date de début
2010-10-31
Date de fin
2013-01-07
Coûts totaux approuvés
CHF 125400.00
Section
20 Förderbereich Life Sciences
Domaine politique NABS
Nicht aufteilbare / nicht zuteilbare Forschung

Disciplines de recherche

  • T490 Biotechnology 100.0%